New York State Common Retirement Fund Cassava Sciences Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Cassava Sciences Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,239 shares of SAVA stock, worth $28,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,239

Previous 15,639 21.74%

Holding current value

$28,639

Previous $193,000 86.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$9.57 - $35.08 $32,538 - $119,272	-3,400 Reduced 21.74%	12,239 $360,000
Q2 2024 Jul 31, 2024	BUY	$12.35 - $26.11 $12 - $26	1 Added 0.01%	15,639 $193,000
Q1 2024 May 07, 2024	SELL	$18.44 - $26.41 $165 - $237	-9 Reduced 0.06%	15,638 $317,000
Q4 2023 Feb 01, 2024	SELL	$12.64 - $30.11 $910 - $2,167	-72 Reduced 0.46%	15,647 $352,000
Q3 2023 Nov 07, 2023	BUY	$16.64 - $25.32 $1,963 - $2,987	118 Added 0.76%	15,719 $262,000
Q2 2023 Aug 07, 2023	SELL	$21.59 - $27.88 $91,239 - $117,820	-4,226 Reduced 21.31%	15,601 $383,000
Q1 2023 May 02, 2023	SELL	$23.46 - $36.44 $182,659 - $283,721	-7,786 Reduced 28.2%	19,827 $478,000
Q4 2022 Jan 30, 2023	BUY	$27.82 - $44.16 $389 - $618	14 Added 0.05%	27,613 $816,000
Q3 2022 Nov 08, 2022	BUY	$16.33 - $51.06 $587 - $1,838	36 Added 0.13%	27,599 $1.15 Million
Q2 2022 Aug 04, 2022	SELL	$17.22 - $38.47 $1,222 - $2,731	-71 Reduced 0.26%	27,563 $775,000
Q1 2022 May 05, 2022	SELL	$32.6 - $53.05 $1,271 - $2,068	-39 Reduced 0.14%	27,634 $1.03 Million
Q4 2021 Feb 02, 2022	SELL	$36.77 - $90.91 $919 - $2,272	-25 Reduced 0.09%	27,673 $1.21 Million
Q3 2021 Nov 02, 2021	SELL	$41.79 - $135.3 $223,158 - $722,502	-5,340 Reduced 16.16%	27,698 $1.72 Million
Q2 2021 Aug 02, 2021	BUY	$32.15 - $89.72 $126,606 - $353,317	3,938 Added 13.53%	33,038 $2.82 Million
Q1 2021 May 11, 2021	BUY	$7.09 - $87.95 $58,138 - $721,190	8,200 Added 39.23%	29,100 $1.31 Million
Q3 2020 Nov 05, 2020	SELL	$2.86 - $11.51 $33,462 - $134,667	-11,700 Reduced 35.89%	20,900 $241,000
Q2 2020 Aug 07, 2020	BUY	$2.04 - $9.64 $66,504 - $314,264	32,600 New	32,600 $100,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $93.8M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Cassava Sciences Inc Transaction History